OVERVIEW

Conundrums in CINV Prevention and Management is organized by prIME Oncology. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.

Release Date: Aug 8, 2019
Expiration Date: Aug 8, 2020

Target Audience:
This educational activity is designed to meet the needs of oncologists, hematologists, nurses, and other healthcare professionals involved in the treatment of patients with CINV.

Topics:-
Picking the right strategy: guidelines vs personalized management
Tackling clinical conundrums in CINV: panel case discussions

Learning Objectives:
After successful completion of this educational activity, participants should be able to:
• Evaluate current antiemetic therapies for the prevention and management of chemotherapy-induced nausea and vomiting (CINV)
• Select optimal antiemetic therapy based on current guidelines and treatment- and patient-related risk factors
• Identify best practices for management of challenging issues such as delayed CINV, anticipatory nausea and vomiting, and breakthrough CINV

Additional details will be posted as soon as information is available.